Antoni Ribas
University of California, Los Angeles
H-index: 159
North America-United States
Top articles of Antoni Ribas
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Correction: ERK mediates interferon gamma-induced melanoma cell death | Molecular Cancer | Ameya Champhekar Rachel Heymans Justin Saco Guillem Turon Font Cynthia Gonzalez | 2024 |
A topical BRAF inhibitor (LUT-014) for treatment of radiodermatitis among women with breast cancer | JAAD international | Sanford Katz Doug Ciuba Antoni Ribas Noa Shelach Galit Zelinger | 2024/6/1 |
The side effect registry immuno-oncology (SERIO)–A tool for systematic analysis of immunotherapy-induced side effects | European Journal of Cancer | Carolin Ertl Theresa Ruf Dirk Mentzer Mingzi Kong Rafaela Kramer | 2024/3/1 |
Integrative systems biology reveals NKG2A-biased immune responses correlate with protection in infectious disease, autoimmune disease, and cancer | Cell Reports | Daniel G Chen Jingyi Xie Jongchan Choi Rachel H Ng Rongyu Zhang | 2024/3/26 |
CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes | Nature Communications | Sameeha Jilani Justin D Saco Edurne Mugarza Aleida Pujol-Morcillo Jeffrey Chokry | 2024/2/9 |
ERK mediates interferon gamma-induced melanoma cell death (vol 22, 165, 2023) | Molecular Cancer | Ameya Champhekar Rachel Heymans Justin Saco Guillem Turon Font Cynthia Gonzalez | 2023/10/6 |
Biopsy analysis of trial S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with anti-PD-1 refractory melanoma | Cancer Research | Katie M Campbell Zaid Bustami Daniel G Chen Egmidio Medina Cynthia R Gonzalez | 2024/3/22 |
A phase 1 study of triple‐targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF‐mutated cancers | Cancer | Alain P Algazi James Moon Christopher D Lao Bartosz Chmielowski Kari L Kendra | 2024/1/23 |
Multiomics analyses reveal functional DNA, methylation pattern changes in clinical transgenic T-cell receptor cell therapy products | Cancer Research | Giulia Protti Cole Peters Moe Kawakami Conner Kidd Varsha Subramanyam | 2024/3/22 |
A Spatial Omnibus Test (SPOT) for Spatial Proteomic Data | bioRxiv | Sarah N Samorodnitsky Katie M Campbell Antoni Ribas Michael C Wu | 2024 |
Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients | European Journal of Cancer | Julie R Brahmer Georgina V Long Omid Hamid Edward B Garon Roy S Herbst | 2024/3/1 |
Abstract CT009: S1512: High response rate with single agent anti-PD-1 in patients with metastatic desmoplastic melanoma | Cancer Research | Kari Kendra Shay Bellasea Zeynep Eroglu Siwen Hu-Lieskovan Katie M Campbell | 2023/4/14 |
Seven-year follow-up of the phase III KEYNOTE-006 study: pembrolizumab versus ipilimumab in advanced melanoma | Journal of Clinical Oncology | Caroline Robert Matteo S Carlino Catriona McNeil Antoni Ribas Jean-Jacques Grob | 2023/8/20 |
IRIS: Discovery of cancer immunotherapy targets arising from pre-mRNA alternative splicing | Proceedings of the National Academy of Sciences | Yang Pan John W Phillips Beatrice D Zhang Miyako Noguchi Eric Kutschera | 2023/5/23 |
Multimodal single-cell and whole-genome sequencing of small, frozen clinical specimens | Nature genetics | Yiping Wang Joy Linyue Fan Johannes C Melms Amit Dipak Amin Yohanna Georgis | 2023/1 |
1180TiP Randomized phase II trial (PORTSIDE) evaluating encorafenib (enco) and binimetinib (bini) plus pembrolizumab (pembro) versus nivolumab (nivo) and ipilimumab (ipi) for … | Annals of Oncology | D Schadendorf R Dummer A Ribas C Robert RJ Sullivan | 2023/10/1 |
Antitumor Immune Responses in B2M-Deficient Cancers | Cancer Immunology Research | Davis Y Torrejon Mildred Galvez Gabriel Abril-Rodriguez Katie M Campbell Egmidio Medina | 2023/12/1 |
CD19/CD20 bispecific chimeric antigen receptor (CAR) in naive/memory T cells for the treatment of relapsed or refractory non-Hodgkin lymphoma | Cancer discovery | Sarah M Larson Christopher M Walthers Brenda Ji Sanaz N Ghafouri Jacob Naparstek | 2023/3/1 |
Preinfusion polyfunctional profiles and cytokine secretion activity of transgenic TCR-T cells, and serum cytokine profiles, are associated with clinical outcomes in sarcoma and … | Cancer Research | Cole W Peters Crystal Quiros Edward X Han Moe Kawakami Conner Kidd | 2023/4/4 |
Multi-modal single-cell analysis of immunotherapy-experienced cutaneous and mucosal melanoma | Cancer Research | Jana Biermann Yiping Wang Linyue Fan Patricia Ho Amit D Amin | 2023/4/4 |
